BSK Group: Non-Profit Organization

What is BISKA?

BISKA (Blinatumomab) is an affordable and accessible cancer drug for people with a sickness called acute lymphoblastic leukemia.

We at BSK have developed a treatment that is in reach for people with acute lymphoblastic leukemia, a type of blood sickness that mostly affects young children and teenagers. This cancer is also the biggest reason for death in this group of people.


We at BSK are a non-profit organization who believe that everyone should be easily able to access healthcare because everyone should be able to receive care with little to no effort.



President: Bethany Law

Vice-president: Susan Young

Finances: Kimia Afshar


Vision: To live in a world where everyone has equal rights and access to lifesaving medicine

Mission: To develop affordable treatment for all populations

Treatment for Acute Lymphoblastic Leukemia is currently one of the highest-costing cancer treatments in the world.


Did you know that drugs for ALL cost around $178,000 per year???

We are excited to give a cheap treatment to people with acute lymphoblastic leukemia. Our company is looking to make the cost of medications cheaper by testing the drugs in countries such as China and India. By working with these countries, we can bring new  technology to them, which can help people with acute lymphoblastic leukemia in countries other than the United States. Lastly, by working with other companies and organizations, we can make the current price of acute lymphoblastic leukemia treatments lower than ever.


BSK Group can meet its goals by working with other organizations and companies such as…

  • Charities
  • Money from the government
  • Research organizations
  • Universities    



Image Retrieved from  on June 14, 2017.
Tags: acutelymphoblasticleukemia, Biska, blinatumomab, BSK, BSKGROUP, cancer, cancersociety, diagnosis, drug trials, leukemia, non-profit organization, treatment